-
肝腺瘤(hepatic adenoma)为肝脏罕见的良性肿瘤,临床及影像检查的误诊率较高。目前随着影像检查水平的提高,临床发病有增高的趋势。本文参考近20年来的大量参考文献及病例报道,综合评价肝腺瘤在各种影像学检查中的表现,希望能对该病的临床诊治提供帮助。
肝腺瘤的影像诊断现状及进展
Status and advances in imaging diagnsis of hepatic adenoma
-
摘要: 肝腺瘤是罕见的肝脏良性肿瘤,由于缺乏特征表现,临床很容易误诊。近年来随着影像学技术的飞速发展,肝腺瘤的检出率逐年增高。该文综合国内外文献,对肝腺瘤的影像学诊断特征作综述,以期提高临床及放射科医生对肝腺瘤的认识,辅助临床正确诊断肝腺瘤。
-
关键词:
- 腺瘤,肝细胞 /
- 体层摄影术,X线计算机 /
- 磁共振成像 /
- 超声检查 /
- 正电子发射断层显像术
Abstract: Hepatic adenoma is a rare benign tumor, which is quite easily misdiagnosed for its non-specific appearance. The great advances in imaging technology have led an increase in the detection rate of hepatic adenoma. This article reviews the recent advances at home and abroad in imaging diagnostic characteristic of hepatic adenoma, in order to raise awareness of clinicians and make accurate judgment. -
[1] Grazioli L, Federle MP, Brancatelli G, et al. Hepatic adenomas: imaging and pathologic findings. Radiographics, 2001, 21(4): 877-892. doi: 10.1148/radiographics.21.4.g01jl04877 [2] 许达生, 陈君禄, 黄昭民. 临床CT诊断学. 广州: 广东科技出版社, 1998.
[3] Edmondson HA, Henderson B, Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med, 1976, 294(9): 470-472. doi: 10.1056/NEJM197602262940904 [4] 正辉, 黄志强, 董家鸿. 亚临床肝癌. 北京: 军事医学科学出版社, 2003.
[5] 彭利, 王顺祥, 张风瑞. 肝细胞腺瘤的诊断和治疗. 中华肝胆外科杂志, 2002, 8(12): 721-722. doi: 10.3760/cma.j.issn.1007-8118.2002.12.004
[6] 金乃善, 唐光健. 肝细胞腺瘤的CT诊断(附三例报告). 中华放射学杂志, 1995, 29(5): 335-337. doi: 10.3760/j.issn:1005-1201.1995.05.011
[7] Ghaferi AA, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg, 2005, 129(6): 1348-1352. doi: 10.1016/j.jtcvs.2004.10.005 [8] Chaib E, Gama-Rodrigues J, Ribeiro MA Jr, et al. Hepatic adenoma. Timing for surgery. Hepatogastroenterology, 2007, 54(77): 1382-1387. [9] 叶彩儿, 陈伟建, 叶民, 等. CT检查肝腺瘤误诊4例报告(结合文献17例分析). 浙江临床医学, 2005, 7(6): 649-650. doi: 10.3969/j.issn.1008-7664.2005.06.077
[10] 叶慧义, 郭智萍, 李俊来, 等. 肝腺瘤的综合影像诊断. 中华放射学杂志, 2002, 36(2): 156-158.
[11] 梁晓辉, 杨予川, 杨庆艳, 等. 肝腺瘤的CT诊断与鉴别. 黑龙江医学, 2007, 31(6): 415-417. doi: 10.3969/j.issn.1004-5775.2007.06.009
[12] Bioulac-Sage P, Balabaud C, Wanless IR. Diagnosis of focal nodu-lar hyperplasia: not so easy. Am J Surg Pathol, 2001, 25(10): 1322-1325. doi: 10.1097/00000478-200110000-00015 [13] Grazioli L, Morana G, Kirchin MA, et al. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology, 2005, 236(1) : 166-177. doi: 10.1148/radiol.2361040338 [14] Corot C, Robert P, Idée JM, et al. Recent advances in iron oxid nanocrystal technology for medical imaging. Adv Drug Deliv Rev, 2006, 58(14): 1471-1504. doi: 10.1016/j.addr.2006.09.013 [15] Daldrup-Link HE, Rydland J, Helbich TH, et al. Quantification of breast tumor mirovascular permeability with feruglucose-enhanced MR imaging: initial phase Ⅱ multicellular trial. Radiology, 2003, 229(3): 885-892. doi: 10.1148/radiol.2293021045 [16] Beets-Tan RG, Van Engelshoven JM, Greve JW. Hepatic adenoma andfocal nodular hyperplasia: MR findings with superparamagne-tic iron oxide-enhanced MRI. Clin Imaging, 1998, 22(3): 211-215. doi: 10.1016/S0899-7071(97)00117-4 [17] Ba-Ssalamah A, Uffmann M, Saini S, et al. Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol, 2009, 19(2): 342-357. doi: 10.1007/s00330-008-1172-x [18] Stroszczynski C, Gaffke G, Gretschel S, et al. Use of SPIO-enhan-ced T1-and T2-weighted images for the diferentiation of liver lesions: an ROC analysis. Rofo, 2003, 175(10): 1368-1375. doi: 10.1055/s-2003-42887 [19] King LJ, Burkill GJC, Scurr ED. MnDPDP enhanced magnetic resonance imaging o focal liver lesions. Clin Radiol, 2002, 57(12): 1047-1057. doi: 10.1053/crad.2002.1117 [20] Kim MJ, Kim JH, Lim JS, et al. Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging. J Magn Reson Imaging, 2004, 20(4): 612-621. doi: 10.1002/jmri.20174 [21] Huppertz A, Haraida S, Kraus A, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations. Radiology, 2005, 234(2): 468-478. doi: 10.1148/radiol.2342040278 [22] 刘丽华, 祁吉. 新型肝脏MRI对比剂对肝细胞腺瘤诊断与鉴别诊断的价值. 国际医学放射学杂志, 2008, 31(2): 118-121.
[23] Macarini L, Marini S, Milillo P, et al. Double-contrast MRI(DC-MRI) in the study of the cirrhotic liver: utility of administering Gd-DTPA as a complement to examinations in which SPIO liver uptake and distribution alterations (SPIO-LUDA) are present and in the identification and characterisation of focal lesions. Radiol Med, 2006, 111(8): 1087-1102. doi: 10.1007/s11547-006-0107-3 [24] 杨建秀, 王从光, 于卫中, 等. 肝腺瘤的超声表现. 医学创新研究, 2006, 3(11): 127.
[25] 龙花. B超诊断肝腺瘤10例报告. 世界今日医学杂志, 2005, 6(3): 191-192.
[26] Brannigan M, Burns PN, Wilson SR. Blood flow patterns in focal liver lesions at microbubble-enhanced US. Radiographics, 2004, 24(4): 921-935. doi: 10.1148/rg.244035158 [27] Kim TK, Jang HJ, Wilson SR. Benign liver masses: imaging with microbubble contrast agents. Ultrasound Q, 2006, 22(1): 31-39. [28] Kim TK, Jang HJ, Burns PN, et al. Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography. AJR Am J Roentgenol, 2008, 190(1): 58-66. doi: 10.2214/AJR.07.2493 [29] Dietrich CF, Schuessler G, Trojan J, et al. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol, 2005, 78(932): 704-707. doi: 10.1259/bjr/88181612 [30] 卢光明, 陈君坤. CT诊断与鉴别诊断. 南京: 东南大学出版社, 1999.
[31] Kume N, Suga K, Nishigauchi K, et al. Characterization of hepatic adenoma with atypical appearance on CT and MRI by radionuclide imaging. Clin Nucl Med, 1997, 22(12): 825-831. doi: 10.1097/00003072-199712000-00004 [32] Magini G, Farsad M, Frigerio M, et al. C-11 acetate oesnot enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. Clin Nucl Med, 2009, 34(10): 659-665.
计量
- 文章访问数: 2161
- HTML全文浏览量: 797
- PDF下载量: 3